Antiverse (AgeTech UK) Biomed

Antiverse is building a world-first computational antibody drug discovery platform to predict antibody-antigen binding and provide antibody drug candidates.

Funding Status: N/A
Industry: UK AgeTech 2020
Number Of Exists: N/A
Technology: AgeTech Companies
Founded Date: N/A
Investor Type: N/A
Headquarters: United Kingdom
Employee Number: N/A
Investment Stage: N/A